Table 2 Anemia and transfusion outcomes of COVID-19 patients in observational cohort
Total (N = 682) | No treatment (N = 155) | Steroids (N = 324) | Steroids and IL-6 inhibitors (N = 201) | P-value | |
|---|---|---|---|---|---|
Developing anemia n, (%) | 517 (76%) | 133 (86%) | 243 (75) | 140 (70%)** | < 0.001 |
Patients transfused n, (%) | 104 (15%) | 37 (24%) | 48 (15%)* | 19 (10%)** | < 0.001 |
No. of RBC units/patient | 2 [1–5] | 3 [2–8] | 3 [1–5] | 1 [0–2]** | < 0.001 |
Days until 1st transfusion | 9 [3–17] | 10 [4–17] | 6 [3–14] | 19 [4–25]* | 0.03 |